Breast cancer, marked by its heterogeneity, is rooted in histological attributes, delineating four distinct subtypes, including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive, and notorious triple-negative breast cancer (TNBC) [3]. Here, ERBB2 is linked to breast cancer.